Alkermes
ALKS
#2321
Rank
S$10.00 B
Marketcap
S$59.55
Share price
-1.43%
Change (1 day)
58.94%
Change (1 year)

EPS for Alkermes (ALKS)

EPS in 2026 (TTM): S-$0.0007780

According to Alkermes's latest financial reports the company's current EPS (TTM) is S-$0.0000000000. In 2025 the company made an earnings per share (EPS) of S$1.90 a decrease over its 2024 EPS that were of S$2.88.

EPS history for Alkermes from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$0.0007780-100.04%
2025S$1.90-34.08%
2024S$2.883.72%
2023S$2.77-323.96%
2022S-$1.24220%
2021S-$0.39-57.19%
2020S-$0.90-44.38%
2019S-$1.62
2017S-$1.33-24.82%
2016S-$1.77-9.87%
2015S-$1.96660%
2014S-$0.26

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$8.61-12,033,301,387,828,041,728.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$6.77-9,457,550,908,645,464,064.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$0.92-1,279,021,170,502,529,280.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$2.55-3,567,802,533,542,780,416.00%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
S$5.83-8,142,500,972,776,666,112.00%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$9.18-12,826,240,470,391,560,192.00%๐Ÿ‡ฌ๐Ÿ‡ง UK
Acorda Therapeutics
ACOR
S-$64.88 90,630,359,278,848,245,760.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$0.58-810,647,220,741,039,872.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel